SCHEMBL4896598

SCHEMBL4896598

Cc1cnn(-c2cccc(Nc3ccc(F)cn3)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 2/20 0.39
MEN1 O00255 1/20 0.39
CYP2C9 P11712 1/20 0.39
KMT2A Q03164 1/20 0.39
BTK Q06187 8/20 0.37
SRC P12931 5/20 0.37
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
LYN P07948 4/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
JAK1 P23458 2/20 0.34
TYK2 P29597 2/20 0.34
JAK2 O60674 1/20 0.34
PDE4D Q08499 1/20 0.34
SYK P43405 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895051 0.86 ALDH1A1 (0.45) ALDH1A1CYP1A2MEN1CYP2C9KMT2A
Hydrochloric Acid SCHEMBL4896673 0.85 ALDH1A1 (0.45) ALDH1A1CYP1A2MEN1CYP2C9KMT2A
SCHEMBL4899608 0.85 CYP1A2 (0.41) ALDH1A1CYP1A2MEN1CYP2C9KMT2A
SCHEMBL4899881 0.85 TSHR (0.39) ALDH1A1CYP1A2MEN1CYP2C9KMT2A
SCHEMBL4904831 0.83 ALDH1A1 (0.39) ALDH1A1CYP1A2MEN1CYP2C9KMT2A
SCHEMBL4903204 0.83 KDM4E (0.43) ALDH1A1CYP1A2MEN1CYP2C9KMT2A
SCHEMBL4892363 0.83 CYP1A2 (0.35) ALDH1A1CYP1A2MEN1CYP2C9KMT2A
Hydrochloric Acid SCHEMBL4904519 0.82 ALDH1A1 (0.38) ALDH1A1CYP1A2MEN1CYP2C9KMT2A
SCHEMBL4902033 0.80 KDM4E (0.45) ALDH1A1MEN1KMT2ABTKSRC
SCHEMBL5332280 0.79 EGLN1 (0.50) MAPTNPSR1JAK1TYK2JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed
CN-1980923-A Polycyclic pyridines as potassium ion channel modulators ICAGEN INC (US) 2007-06-13 CN disclosed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP disclosed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 ALDH1A1 3179/4885CYP1A2 2682/4885MEN1 2428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.